— Know what they know.
Not Investment Advice
Also trades as: APN.JO (JNB) · $vol 13M · APNHF (OTC) · $vol 0M

APNHY OTC

Aspen Pharmacare Holdings Limited
1W: -5.3% 1M: +8.2% 3M: +1.2% YTD: +44.7% 1Y: +84.1% 3Y: +9.3% 5Y: -38.7%
$9.52
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Buy · Power 68 · $4.2B mcap · 367M float · 0.0002% daily turnover · Short 61% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$4.2B
52W Range5.25-10.05
Volume6,000
Avg Volume675
Beta0.40
Dividend$0.12
Analyst Ratings
No analyst coverage
Company Info
CEOStephen Bradley Saad
Employees9,557
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2010-04-05
Aspen Place
Durban, NL 2191
ZA
27 31 580 8600
About Aspen Pharmacare Holdings Limited

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and markets specialty and branded pharmaceutical products in Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia. It operates through Commercial Pharmaceuticals and Manufacturing segments. The company offers injectables for therapeutic areas, such as anaesthetics, anticoagulants, antithrombotic agents, analgesics, and hormone replacement medicines under the Arixtra, Diprivan, Fraxiparine, Marcaine, Sustanon, and Xylocaine brands; over-the-counter medicines under the Emla, Maltofer, Ovestin, Solpadeine, and Xylocaine brands; and prescription products for anti-inflammatories, immunosuppressants, hypothyroidism, anti-gout, analgesics, and corticosteroids under the Eltroxin, Imuran, Lipitor, Lyrica, and Zyloric brands. It also manufactures active pharmaceutical ingredients, finished dose forms, and heparins, as well as steriles, oral solid doses, liquids, semi-solids, and biologicals. The company exports its products. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms